Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.

[1]  C. Iacobuzio-Donahue,et al.  p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells , 2016, Oncogene.

[2]  K. Strebhardt,et al.  Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy , 2016, Oncogene.

[3]  Jun Yu,et al.  Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability. , 2016, Cancer research.

[4]  E. Lentsch,et al.  Mucinous Adenocarcinoma of the Salivary Gland , 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  S. Horswell,et al.  Mutation of cancer driver MLL2 results in transcription stress and genome instability , 2016, Genes & development.

[6]  G. Zhuang,et al.  A candidate gastric stem/progenitor cell marker revealed by genome‐wide analysis , 2016, The Journal of pathology.

[7]  M. Lenardo,et al.  Reprogramming of Polycomb-Mediated Gene Silencing in Embryonic Stem Cells by the miR-290 Family and the Methyltransferase Ash1l , 2015, Stem cell reports.

[8]  K. Basso,et al.  Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis , 2015, Nature Medicine.

[9]  G. Kong,et al.  UTX inhibits EMT‐induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1 , 2015, EMBO reports.

[10]  C. Chai,et al.  Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma , 2015, Journal of Clinical Pathology.

[11]  H. Hondermarck,et al.  FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation , 2015, Cellular and Molecular Life Sciences.

[12]  E. Zackai,et al.  Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. , 2015, Human molecular genetics.

[13]  S. Malek,et al.  Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. , 2015, The Journal of clinical investigation.

[14]  C. Scott,et al.  Prioritizing therapeutic targets using patient-derived xenograft models. , 2015, Biochimica et biophysica acta.

[15]  N. Schultz,et al.  Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder. , 2015, European urology.

[16]  R. Pinheiro,et al.  Proteins of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patients with myelodysplastic syndrome , 2015, Journal of Clinical Pathology.

[17]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[18]  A. Musacchio,et al.  A molecular basis for the differential roles of Bub1 and BubR1 in the spindle assembly checkpoint , 2015, eLife.

[19]  G. Shapiro,et al.  The Biology and Clinical Development of MEK Inhibitors for Cancer , 2014, Drugs.

[20]  Zhiming Cai,et al.  Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer , 2014, Clinical Cancer Research.

[21]  Jian Sun,et al.  Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.

[22]  S. Kaneko,et al.  TGF-β Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the α-Fetoprotein Promoter , 2014, Journal of signal transduction.

[23]  A. Adjei,et al.  The clinical development of MEK inhibitors , 2014, Nature Reviews Clinical Oncology.

[24]  S. Xiong,et al.  Mll2 Controls Cardiac Lineage Differentiation of Mouse Embryonic Stem Cells by Promoting H3K4me3 Deposition at Cardiac-Specific Genes , 2014, Stem Cell Reviews and Reports.

[25]  F. Speleman,et al.  The H3K27me3 demethylase UTX in normal development and disease , 2014, Epigenetics.

[26]  Kai Wang,et al.  Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy , 2014, Modern Pathology.

[27]  A. F. Stewart,et al.  Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant , 2014, Development.

[28]  M. Pasca di Magliano,et al.  Kras as a key oncogene and therapeutic target in pancreatic cancer , 2014, Front. Physiol..

[29]  Manuel Hidalgo,et al.  Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.

[30]  Samuel A. Williams,et al.  Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century , 2013, Laboratory Investigation.

[31]  Alexander S. Garruss,et al.  The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells , 2013, Nature Structural &Molecular Biology.

[32]  Steven J. M. Jones,et al.  Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma , 2013, Acta Neuropathologica.

[33]  Jun Zhu,et al.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells. , 2013, Cancer discovery.

[34]  L. Liau,et al.  Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation , 2013, Nature Genetics.

[35]  Melanie A. Huntley,et al.  Recurrent R-spondin fusions in colon cancer , 2012, Nature.

[36]  Gang Zhao,et al.  Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas , 2012, Clinical Neurology and Neurosurgery.

[37]  B. Ragsdale,et al.  Mucoepidermoid carcinoma of the parotid presenting as periauricular cystic nodules: a series of four cases , 2012, Journal of cutaneous pathology.

[38]  A. Zhu,et al.  Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. , 2012, Cancer research.

[39]  W. McDonald,et al.  Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones[S] , 2012, Journal of Lipid Research.

[40]  Sven Laur,et al.  Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..

[41]  David I. Smith,et al.  Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma , 2011, The Laryngoscope.

[42]  J. Rousset,et al.  Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides , 2010, Nucleic acids research.

[43]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[44]  G. Lozano,et al.  You can win by losing: p53 mutations in rhabdomyosarcomas , 2010, The Journal of pathology.

[45]  J. Neumann,et al.  Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. , 2009, Pathology, research and practice.

[46]  R. Kolde,et al.  Mining for coexpression across hundreds of datasets using novel rank aggregation and visualization methods , 2009, Genome Biology.

[47]  P. Gönczy,et al.  NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5/GPR/Gα , 2009, Nature Cell Biology.

[48]  J. Weinstein,et al.  Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance. , 2008, Neoplasia.

[49]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[50]  R. Weber,et al.  Translocation t(6;14) as the Sole Chromosomal Abnormality in Adenoid Cystic Carcinoma of the Base of Tongue , 2007, Head and neck pathology.

[51]  C. Croce,et al.  Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth , 2006, Molecular and Cellular Biology.

[52]  T. Miki,et al.  Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. , 2006, Oncology reports.

[53]  Michael Goggins,et al.  Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. , 2006, Gastroenterology.

[54]  Yutaka Miura,et al.  Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer , 2005, Nature Genetics.

[55]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[56]  John I. Clark,et al.  Shotgun identification of protein modifications from protein complexes and lens tissue , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Joh,et al.  Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1 , 2001, Oncogene.

[58]  Y. Samuels,et al.  The head and neck cancer cell oncogenome : a platform for the development of precision molecular therapies , 2014 .

[59]  K. Mishima,et al.  Mucinous adenocarcinoma of minor salivary glands: a high-grade malignancy prone to lymph node metastasis , 2008, Virchows Archiv.